High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer

This publication has 15 references indexed in Scilit:

• Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors
  European Journal of Cancer and Clinical Oncology, 1988
• Cisplatin Plus VP16 213 in Refractory Ovarian Carcinoma
  American Journal of Clinical Oncology, 1987
• Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer
  American Journal of Obstetrics and Gynecology, 1985
• High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.
  BMJ, 1985
• Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer
  Gynecologic Oncology, 1984
• Review of etoposide single-agent activity
  Cancer Treatment Reviews, 1982
• USE OF HIGH DOSE CIS-DICHLORODIAMMINE PLATINUM (II) (NSC-119875)+ FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARY
  BJOG: An International Journal of Obstetrics and Gynaecology, 1981
• High-dose platinum for the treatment of refractory ovarian cancer
  Gynecologic Oncology, 1981
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
  British Journal of Cancer, 1977
• The chemotherapy of ovarian carcinoma
  Cancer Treatment Reviews, 1974